nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—saliva—nicotine dependence	0.0699	0.3	CbGeAlD
Mesalazine—Cardiac flutter—Varenicline—nicotine dependence	0.0457	0.06	CcSEcCtD
Mesalazine—Pleurisy—Varenicline—nicotine dependence	0.0307	0.0404	CcSEcCtD
Mesalazine—CHUK—cardiovascular system—nicotine dependence	0.0296	0.127	CbGeAlD
Mesalazine—IKBKB—cardiovascular system—nicotine dependence	0.0201	0.0863	CbGeAlD
Mesalazine—Haematochezia—Varenicline—nicotine dependence	0.0186	0.0245	CcSEcCtD
Mesalazine—Rash generalised—Varenicline—nicotine dependence	0.0176	0.0232	CcSEcCtD
Mesalazine—ALOX5—cardiovascular system—nicotine dependence	0.0166	0.0715	CbGeAlD
Mesalazine—Pancreatitis acute—Varenicline—nicotine dependence	0.0162	0.0213	CcSEcCtD
Mesalazine—CHUK—brain—nicotine dependence	0.0145	0.0623	CbGeAlD
Mesalazine—MPO—cardiovascular system—nicotine dependence	0.0141	0.0605	CbGeAlD
Mesalazine—Urine abnormality—Varenicline—nicotine dependence	0.0135	0.0178	CcSEcCtD
Mesalazine—Urine analysis abnormal—Varenicline—nicotine dependence	0.0127	0.0168	CcSEcCtD
Mesalazine—Platelet count decreased—Varenicline—nicotine dependence	0.0126	0.0166	CcSEcCtD
Mesalazine—PPARG—cardiovascular system—nicotine dependence	0.0125	0.0537	CbGeAlD
Mesalazine—Psoriasis—Varenicline—nicotine dependence	0.0119	0.0157	CcSEcCtD
Mesalazine—Parosmia—Varenicline—nicotine dependence	0.0116	0.0152	CcSEcCtD
Mesalazine—Upset stomach—Varenicline—nicotine dependence	0.0114	0.015	CcSEcCtD
Mesalazine—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.0111	0.0146	CcSEcCtD
Mesalazine—Laryngeal pain—Varenicline—nicotine dependence	0.011	0.0145	CcSEcCtD
Mesalazine—Intestinal obstruction—Varenicline—nicotine dependence	0.011	0.0145	CcSEcCtD
Mesalazine—Thrombosis—Varenicline—nicotine dependence	0.0106	0.0139	CcSEcCtD
Mesalazine—Menorrhagia—Varenicline—nicotine dependence	0.0101	0.0133	CcSEcCtD
Mesalazine—Scotoma—Varenicline—nicotine dependence	0.00987	0.013	CcSEcCtD
Mesalazine—IKBKB—brain—nicotine dependence	0.00986	0.0423	CbGeAlD
Mesalazine—Rhinorrhoea—Varenicline—nicotine dependence	0.00925	0.0122	CcSEcCtD
Mesalazine—Acne—Varenicline—nicotine dependence	0.00891	0.0117	CcSEcCtD
Mesalazine—Tenderness—Varenicline—nicotine dependence	0.00859	0.0113	CcSEcCtD
Mesalazine—ALOX5—brain—nicotine dependence	0.00817	0.0351	CbGeAlD
Mesalazine—Leukocytosis—Varenicline—nicotine dependence	0.00797	0.0105	CcSEcCtD
Mesalazine—Musculoskeletal pain—Varenicline—nicotine dependence	0.00758	0.00997	CcSEcCtD
Mesalazine—Abnormal dreams—Varenicline—nicotine dependence	0.00741	0.00974	CcSEcCtD
Mesalazine—Eructation—Varenicline—nicotine dependence	0.00736	0.00968	CcSEcCtD
Mesalazine—Influenza like illness—Varenicline—nicotine dependence	0.00728	0.00957	CcSEcCtD
Mesalazine—Dry eye—Varenicline—nicotine dependence	0.00692	0.0091	CcSEcCtD
Mesalazine—MPO—brain—nicotine dependence	0.00691	0.0297	CbGeAlD
Mesalazine—Mouth ulceration—Varenicline—nicotine dependence	0.00678	0.00891	CcSEcCtD
Mesalazine—PTGS1—cardiovascular system—nicotine dependence	0.00668	0.0287	CbGeAlD
Mesalazine—Hypertonia—Varenicline—nicotine dependence	0.00657	0.00864	CcSEcCtD
Mesalazine—PTGS2—cardiovascular system—nicotine dependence	0.00639	0.0274	CbGeAlD
Mesalazine—Lymphadenopathy—Varenicline—nicotine dependence	0.00638	0.00838	CcSEcCtD
Mesalazine—PPARG—brain—nicotine dependence	0.00613	0.0263	CbGeAlD
Mesalazine—Disorientation—Varenicline—nicotine dependence	0.00608	0.008	CcSEcCtD
Mesalazine—Deafness—Varenicline—nicotine dependence	0.00608	0.008	CcSEcCtD
Mesalazine—Eczema—Varenicline—nicotine dependence	0.00605	0.00796	CcSEcCtD
Mesalazine—Eye pain—Varenicline—nicotine dependence	0.00603	0.00792	CcSEcCtD
Mesalazine—Renal failure acute—Varenicline—nicotine dependence	0.00589	0.00775	CcSEcCtD
Mesalazine—Libido decreased—Varenicline—nicotine dependence	0.00587	0.00771	CcSEcCtD
Mesalazine—Increased appetite—Varenicline—nicotine dependence	0.00579	0.00761	CcSEcCtD
Mesalazine—Atrial fibrillation—Varenicline—nicotine dependence	0.00574	0.00755	CcSEcCtD
Mesalazine—Thirst—Varenicline—nicotine dependence	0.00572	0.00752	CcSEcCtD
Mesalazine—Arthritis—Varenicline—nicotine dependence	0.0056	0.00736	CcSEcCtD
Mesalazine—Lethargy—Varenicline—nicotine dependence	0.00555	0.0073	CcSEcCtD
Mesalazine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00544	0.00715	CcSEcCtD
Mesalazine—Osteoarthritis—Varenicline—nicotine dependence	0.00544	0.00715	CcSEcCtD
Mesalazine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0054	0.0071	CcSEcCtD
Mesalazine—Affect lability—Varenicline—nicotine dependence	0.00535	0.00704	CcSEcCtD
Mesalazine—Migraine—Varenicline—nicotine dependence	0.00535	0.00704	CcSEcCtD
Mesalazine—Mood swings—Varenicline—nicotine dependence	0.00515	0.00678	CcSEcCtD
Mesalazine—Liver function test abnormal—Varenicline—nicotine dependence	0.00502	0.0066	CcSEcCtD
Mesalazine—PTGS2—midbrain—nicotine dependence	0.00499	0.0214	CbGeAlD
Mesalazine—Dry skin—Varenicline—nicotine dependence	0.00499	0.00656	CcSEcCtD
Mesalazine—Abdominal pain upper—Varenicline—nicotine dependence	0.00497	0.00653	CcSEcCtD
Mesalazine—Breast disorder—Varenicline—nicotine dependence	0.00492	0.00646	CcSEcCtD
Mesalazine—Cramp muscle—Varenicline—nicotine dependence	0.0049	0.00644	CcSEcCtD
Mesalazine—Nasopharyngitis—Varenicline—nicotine dependence	0.00486	0.0064	CcSEcCtD
Mesalazine—Gastritis—Varenicline—nicotine dependence	0.00481	0.00633	CcSEcCtD
Mesalazine—Abdominal distension—Varenicline—nicotine dependence	0.00473	0.00622	CcSEcCtD
Mesalazine—Asthma—Varenicline—nicotine dependence	0.0047	0.00618	CcSEcCtD
Mesalazine—Dysphagia—Varenicline—nicotine dependence	0.0047	0.00618	CcSEcCtD
Mesalazine—Angina pectoris—Varenicline—nicotine dependence	0.00458	0.00602	CcSEcCtD
Mesalazine—Bronchitis—Varenicline—nicotine dependence	0.00452	0.00595	CcSEcCtD
Mesalazine—Abdominal discomfort—Varenicline—nicotine dependence	0.00451	0.00593	CcSEcCtD
Mesalazine—Pollakiuria—Varenicline—nicotine dependence	0.00434	0.00571	CcSEcCtD
Mesalazine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00429	0.00564	CcSEcCtD
Mesalazine—Weight increased—Varenicline—nicotine dependence	0.00428	0.00563	CcSEcCtD
Mesalazine—Infestation NOS—Varenicline—nicotine dependence	0.00419	0.00551	CcSEcCtD
Mesalazine—Infestation—Varenicline—nicotine dependence	0.00419	0.00551	CcSEcCtD
Mesalazine—Depression—Varenicline—nicotine dependence	0.00418	0.0055	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00416	0.00547	CcSEcCtD
Mesalazine—Stomatitis—Varenicline—nicotine dependence	0.00409	0.00537	CcSEcCtD
Mesalazine—Conjunctivitis—Varenicline—nicotine dependence	0.00407	0.00536	CcSEcCtD
Mesalazine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00396	0.00521	CcSEcCtD
Mesalazine—Epistaxis—Varenicline—nicotine dependence	0.00395	0.0052	CcSEcCtD
Mesalazine—Sinusitis—Varenicline—nicotine dependence	0.00393	0.00517	CcSEcCtD
Mesalazine—Urinary tract disorder—Varenicline—nicotine dependence	0.00372	0.00489	CcSEcCtD
Mesalazine—Oedema peripheral—Varenicline—nicotine dependence	0.00371	0.00487	CcSEcCtD
Mesalazine—Connective tissue disorder—Varenicline—nicotine dependence	0.0037	0.00486	CcSEcCtD
Mesalazine—Urethral disorder—Varenicline—nicotine dependence	0.00369	0.00485	CcSEcCtD
Mesalazine—Erythema multiforme—Varenicline—nicotine dependence	0.00356	0.00468	CcSEcCtD
Mesalazine—Eye disorder—Varenicline—nicotine dependence	0.00352	0.00462	CcSEcCtD
Mesalazine—Tinnitus—Varenicline—nicotine dependence	0.00351	0.00461	CcSEcCtD
Mesalazine—Cardiac disorder—Varenicline—nicotine dependence	0.00349	0.00459	CcSEcCtD
Mesalazine—L-DOPA—DRD2—nicotine dependence	0.00349	0.518	CrCbGaD
Mesalazine—Angiopathy—Varenicline—nicotine dependence	0.00341	0.00449	CcSEcCtD
Mesalazine—Immune system disorder—Varenicline—nicotine dependence	0.0034	0.00447	CcSEcCtD
Mesalazine—Mediastinal disorder—Varenicline—nicotine dependence	0.00339	0.00446	CcSEcCtD
Mesalazine—Chills—Varenicline—nicotine dependence	0.00338	0.00444	CcSEcCtD
Mesalazine—Mental disorder—Varenicline—nicotine dependence	0.0033	0.00434	CcSEcCtD
Mesalazine—PTGS1—brain—nicotine dependence	0.00328	0.0141	CbGeAlD
Mesalazine—Erythema—Varenicline—nicotine dependence	0.00328	0.00431	CcSEcCtD
Mesalazine—Dopamine—DRD2—nicotine dependence	0.00324	0.482	CrCbGaD
Mesalazine—Flatulence—Varenicline—nicotine dependence	0.00323	0.00424	CcSEcCtD
Mesalazine—Dysgeusia—Varenicline—nicotine dependence	0.00321	0.00422	CcSEcCtD
Mesalazine—Back pain—Varenicline—nicotine dependence	0.00317	0.00417	CcSEcCtD
Mesalazine—Muscle spasms—Varenicline—nicotine dependence	0.00315	0.00414	CcSEcCtD
Mesalazine—PTGS2—brain—nicotine dependence	0.00313	0.0135	CbGeAlD
Mesalazine—Vision blurred—Varenicline—nicotine dependence	0.00309	0.00406	CcSEcCtD
Mesalazine—Tremor—Varenicline—nicotine dependence	0.00307	0.00404	CcSEcCtD
Mesalazine—Ill-defined disorder—Varenicline—nicotine dependence	0.00304	0.004	CcSEcCtD
Mesalazine—Anaemia—Varenicline—nicotine dependence	0.00303	0.00398	CcSEcCtD
Mesalazine—Angioedema—Varenicline—nicotine dependence	0.00299	0.00394	CcSEcCtD
Mesalazine—Malaise—Varenicline—nicotine dependence	0.00295	0.00388	CcSEcCtD
Mesalazine—Vertigo—Varenicline—nicotine dependence	0.00294	0.00387	CcSEcCtD
Mesalazine—Syncope—Varenicline—nicotine dependence	0.00294	0.00386	CcSEcCtD
Mesalazine—Palpitations—Varenicline—nicotine dependence	0.00289	0.00381	CcSEcCtD
Mesalazine—Loss of consciousness—Varenicline—nicotine dependence	0.00288	0.00379	CcSEcCtD
Mesalazine—Cough—Varenicline—nicotine dependence	0.00286	0.00376	CcSEcCtD
Mesalazine—Hypertension—Varenicline—nicotine dependence	0.00283	0.00372	CcSEcCtD
Mesalazine—Myalgia—Varenicline—nicotine dependence	0.00279	0.00367	CcSEcCtD
Mesalazine—Chest pain—Varenicline—nicotine dependence	0.00279	0.00367	CcSEcCtD
Mesalazine—Arthralgia—Varenicline—nicotine dependence	0.00279	0.00367	CcSEcCtD
Mesalazine—Anxiety—Varenicline—nicotine dependence	0.00278	0.00365	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00277	0.00364	CcSEcCtD
Mesalazine—Discomfort—Varenicline—nicotine dependence	0.00276	0.00362	CcSEcCtD
Mesalazine—Dry mouth—Varenicline—nicotine dependence	0.00273	0.00359	CcSEcCtD
Mesalazine—Oedema—Varenicline—nicotine dependence	0.00267	0.00352	CcSEcCtD
Mesalazine—Infection—Varenicline—nicotine dependence	0.00266	0.00349	CcSEcCtD
Mesalazine—Shock—Varenicline—nicotine dependence	0.00263	0.00346	CcSEcCtD
Mesalazine—Nervous system disorder—Varenicline—nicotine dependence	0.00262	0.00345	CcSEcCtD
Mesalazine—Thrombocytopenia—Varenicline—nicotine dependence	0.00262	0.00344	CcSEcCtD
Mesalazine—Tachycardia—Varenicline—nicotine dependence	0.00261	0.00343	CcSEcCtD
Mesalazine—Skin disorder—Varenicline—nicotine dependence	0.0026	0.00341	CcSEcCtD
Mesalazine—Hyperhidrosis—Varenicline—nicotine dependence	0.00258	0.0034	CcSEcCtD
Mesalazine—Anorexia—Varenicline—nicotine dependence	0.00255	0.00335	CcSEcCtD
Mesalazine—Hypotension—Varenicline—nicotine dependence	0.0025	0.00329	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00244	0.0032	CcSEcCtD
Mesalazine—Insomnia—Varenicline—nicotine dependence	0.00242	0.00318	CcSEcCtD
Mesalazine—Dyspnoea—Varenicline—nicotine dependence	0.00238	0.00313	CcSEcCtD
Mesalazine—Somnolence—Varenicline—nicotine dependence	0.00238	0.00313	CcSEcCtD
Mesalazine—Dyspepsia—Varenicline—nicotine dependence	0.00235	0.00309	CcSEcCtD
Mesalazine—Decreased appetite—Varenicline—nicotine dependence	0.00232	0.00306	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00231	0.00304	CcSEcCtD
Mesalazine—Fatigue—Varenicline—nicotine dependence	0.0023	0.00303	CcSEcCtD
Mesalazine—Pain—Varenicline—nicotine dependence	0.00229	0.00301	CcSEcCtD
Mesalazine—Constipation—Varenicline—nicotine dependence	0.00229	0.00301	CcSEcCtD
Mesalazine—Feeling abnormal—Varenicline—nicotine dependence	0.0022	0.0029	CcSEcCtD
Mesalazine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00219	0.00287	CcSEcCtD
Mesalazine—Urticaria—Varenicline—nicotine dependence	0.00212	0.00279	CcSEcCtD
Mesalazine—Abdominal pain—Varenicline—nicotine dependence	0.00211	0.00278	CcSEcCtD
Mesalazine—Body temperature increased—Varenicline—nicotine dependence	0.00211	0.00278	CcSEcCtD
Mesalazine—Hypersensitivity—Varenicline—nicotine dependence	0.00197	0.00259	CcSEcCtD
Mesalazine—Asthenia—Varenicline—nicotine dependence	0.00192	0.00252	CcSEcCtD
Mesalazine—Pruritus—Varenicline—nicotine dependence	0.00189	0.00249	CcSEcCtD
Mesalazine—Diarrhoea—Varenicline—nicotine dependence	0.00183	0.00241	CcSEcCtD
Mesalazine—Dizziness—Varenicline—nicotine dependence	0.00177	0.00232	CcSEcCtD
Mesalazine—Vomiting—Varenicline—nicotine dependence	0.0017	0.00224	CcSEcCtD
Mesalazine—Rash—Varenicline—nicotine dependence	0.00169	0.00222	CcSEcCtD
Mesalazine—Dermatitis—Varenicline—nicotine dependence	0.00168	0.00221	CcSEcCtD
Mesalazine—Headache—Varenicline—nicotine dependence	0.00167	0.0022	CcSEcCtD
Mesalazine—Nausea—Varenicline—nicotine dependence	0.00159	0.00209	CcSEcCtD
